Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease. - Howe MD; Britton KJ; Joyce HE; Menard W; Emrani S; Kunicki ZJ; Faust MA; Dawson BC; Riddle MC; Huey ED; Janelidze S; Hansson O; et al. (Research square, 2024)